Imidazole propionate is a metabolite produced from the gut microbiota’s metabolism of histidine, which has been linked to insulin resistance and T2DM by disrupting the insulin signaling pathway through activation of the mammalian target of rapamycin complex 1 (mTORC1) in the liver. Here, INS is linked to Insulin resistance.